Stay updated with breaking news from Median Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, "Median" or "The Company") announced today that the Company will be participating in the 2024 American Society of
Press release - For immediate release May 29, 2024 - 5:45 pm CEST Median Technologies to participate in the 2024 ASCO...
At ECR23, Median will unveil the latest developments for eyonis alongside its AI-powered clinical trial imaging services
Pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News:Median Technologies (Paris:ALMDT):Total number of shares18,404,608Number of real voting rights* (excluding treasury shares**)18,349,997Theoretical num...
17.01.2024 - Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) today announces that it has achieved very positive results from the independent verification study for its CADe/CADx1 SaMD eyonis2 LCS (Lung Cancer Screening). This ... Seite 1